From: Pemetrexed plus cisplatin/carboplatin in previously treated locally advanced or metastatic non-small cell lung cancer patients
Response
N (%)
95% CI (%)
CR
-
PR
7(13.2)
5.48 to 25.34
SD
36(67.9)
56.68 to 80.08
PD
10(18.9)
9.44 to 31.97